m-Aminoacetanilide
Formula : C8-H10-N2-O
CAS :
102-28-3
4-13-00-00084 (Beilstein Handbook Reference)
m-Acetaminoaniline
m-(Acetylamino)aniline
3-Acetylaminoaniline
N-Acetyl-m-fenylendiamin [Czech]
N-Acetyl-m-phenylenediamine
3-Aminoacetanilid [Czech]
m-Aminoacetanilide
3'-Aminoacetanilide
1-Amino-3-(acetylamino)benzene
3-Amino-N-acetylaniline
N-(3-Aminophenyl)acetamide
BRN 0775952
CCRIS 4574
EINECS 203-021-5
NSC 165576
3-Aminoacetanilid
N-Acetyl-m-fenylendiamin
m-Aminocinnamic acid
Formula :
CAS :
1664-56-8
m-Aminooxanilic acid
Formula : C8-H8-N2-O3
CAS :
101-09-07
m-Aminophenol sulfate
Formula : C6-H7-N-O.1/2H2-O4-S
CAS :
68239-81-6
m-Amsacrine
Formula : C21-H19-N3-O3-S.Cl-H
CAS :
54301-15-4
4'-(9-Acridinylamino)methanesulfon-m-aniside monohydrochloride
N-(4-(9-Acridinylamino)-3-methoxyphenyl)-methanesulfonamide monohydrochloride
N-(4-(9-Acridinylamino)-3-methoxyphenyl)methanesulfonamidemonohydrochloride
m-Amsa hydrochloride
m-Amsacrine
Methanesulfon-m-anisidine| 4'-((9-acridinyl)amino)-| hydrochloride
Methanesulfone-m-anisidine-4'-((9-acridinyl)amino) hydrochloride
Methanesulfonyl-m-anisidine| 4'-(9-acridinylamino)-| monohydrochloride
NCI-C03190
NSC 141549
CCRIS 9342
UNII-U66HX4K4CO
Aminoacridine derivative that is a potent intercalating antineoplastic agent. It is effective in the treatment of acute leukemias and malignant lymphomas, but has poor activity in the treatment of solid tumors. It is frequently used in combination with other antineoplastic agents in chemotherapy protocols. It produces consistent but acceptable myelosuppression and cardiotoxic effects.
m-Anisaldehyde, 2-hydroxy-, dimethylhydrazone
Formula : C10-H14-N2-O2
CAS :
102583-80-2
m-Anisaldehyde, 2-hydroxy-, oxime
Formula : C8-H9-N-O3
CAS :
2169-99-5